1,192 results on '"CLEMENTI , MASSIMO"'
Search Results
2. Unveiling the role of PUS7-mediated pseudouridylation in host protein interactions specific for the SARS-CoV-2 RNA genome
3. Human herpesvirus 6–specific T-cell immunity in allogeneic hematopoietic stem cell transplant recipients
4. Unconventional CD147‐dependent platelet activation elicited by SARS‐CoV‐2 in COVID‐19
5. The interferon landscape along the respiratory tract impacts the severity of COVID-19
6. Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors
7. Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy
8. Semen infections in men with primary infertility in the real-life setting
9. Anti-HIV Humoral Response Induced by Different Anti-Idiotype Antibody Formats: An In Silico and In Vivo Approach
10. Synergy evaluation of anti-Herpes Simplex Virus type 1 and 2 compounds acting on different steps of virus life cycle
11. Nanosphere’s Verigene® Blood Culture Assay to Detect Multidrug-Resistant Gram-Negative Bacterial Outbreak: A Prospective Study on 79 Hematological Patients in a Country with High Prevalence of Antimicrobial Resistance
12. The Microbiome of the Prostate Tumor Microenvironment
13. Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge
14. Interferon β-1a (IFNβ-1a) in COVID-19 patients (INTERCOP): study protocol for a randomized controlled trial
15. Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols
16. Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patients
17. Human Herpesvirus 6 Infection Following Haploidentical Transplantation: Immune Recovery and Outcome
18. Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes
19. Rational Dosing Strategies of Colistin: What About Resistance?
20. High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19
21. Smallpox vaccination‐elicited antibodies cross‐neutralize 2022‐Monkeypox virus Clade II
22. Virus-induced preferential antibody gene-usage and its importance in humoral autoimmunity
23. Antibiotic appropriateness for Gram-negative bloodstream infections: impact of infectious disease consultation
24. HCV E2 core structures and mAbs: something is still missing
25. Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: Epitope definition and implications in risk stratification of patients under natalizumab therapy
26. Enteric Microbiome Markers as Early Predictors of Clinical Outcome in Allogeneic Hematopoietic Stem Cell Transplant: Results of a Prospective Study in Adult Patients
27. Cytomegalovirus-specific T cells restricted for shared and donor human leukocyte antigens differentially impact on Cytomegalovirus reactivation risk after allogeneichematopoietic stem cell transplantation
28. Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort Study
29. Epidemiological and Clinical Features of SARS-CoV-2 Variants Circulating between April-December 2021 in Italy
30. Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools
31. The interplay of extracellular matrix and microbiome in urothelial bladder cancer
32. Clinical, epidemiological and virological features of acute hepatitis B in Italy
33. Anti-hepatitis C virus E2 (HCV/E2) glycoprotein monoclonal antibodies and neutralization interference
34. A Human Stem Cell-Derived Neurosensory–Epithelial Circuitry on a Chip to Model Herpes Simplex Virus Reactivation
35. Discovering host protein interactions specific for SARS-CoV-2 RNA genome
36. Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2
37. Cross-resistance Profile of the Novel Integrase Inhibitor Dolutegravir (S/GSK1349572) Using Clonal Viral Variants Selected in Patients Failing Raltegravir
38. Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort Study
39. Clinical characterization and whole genome sequence-based typing of two cases of endophthalmitis due to Listeria monocytogenes
40. A potential role for monoclonal antibodies in prophylactic and therapeutic treatment of influenza
41. Multicenter comparative study of Epstein–Barr virus DNA quantification for virological monitoring in transplanted patients
42. Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases
43. Nanopore ReCappable sequencing maps SARS-CoV-2 5′ capping sites and provides new insights into the structure of sgRNAs
44. Persistent Symptomless Human Metapneumovirus Infection in Hematopoietic Stem Cell Transplant Recipients
45. Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein
46. Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro
47. Monoclonal antibodies isolated from human B cells neutralize a broad range of H1 subtype influenza A viruses including swine-origin Influenza virus (S-OIV)
48. Adaptive immunity against gut microbiota enhances apoE-mediated immune regulation and reduces atherosclerosis and western-diet-related inflammation
49. Microbiome markers are early predictors of acute GVHD in allogeneic hematopoietic stem cell transplant recipients
50. Identification of Two Distinct Subsets of Long-Term Nonprogressors with Divergent Viral Activity by Stromal-Derived Factor 1 Chemokine Gene Polymorphism Analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.